Literature DB >> 34850744

MIF but not MIF-2 recruits inflammatory macrophages in an experimental polymicrobial sepsis model.

Pathricia Veronica Tilstam1,2, Wibke Schulte1,3,4,5, Thomas Holowka1, Bong-Sung Kim1,6,7, Jessica Nouws1, Maor Sauler1, Marta Piecychna1, Georgios Pantouris8,9, Elias Lolis8, Lin Leng1, Jürgen Bernhagen10,11, Günter Fingerle-Rowson12, Richard Bucala1.   

Abstract

Excessive inflammation drives the progression from sepsis to septic shock. Macrophage migration inhibitory factor (MIF) is of interest because MIF promoter polymorphisms predict mortality in different infections, and anti-MIF antibody improves survival in experimental models when administered 8 hours after infectious insult. The recent description of a second MIF superfamily member, D-dopachrome tautomerase (D-DT/MIF-2), prompted closer investigation of MIF-dependent responses. We subjected Mif-/- and Mif-2-/- mice to polymicrobial sepsis and observed a survival benefit with Mif but not Mif-2 deficiency. Survival was associated with reduced numbers of small peritoneal macrophages (SPMs) that, in contrast to large peritoneal macrophages (LPMs), were recruited into the peritoneal cavity. LPMs produced higher quantities of MIF than SPMs, but SPMs expressed higher levels of inflammatory cytokines and the MIF receptors CD74 and CXCR2. Adoptive transfer of WT SPMs into Mif-/- hosts reduced the protective effect of Mif deficiency in polymicrobial sepsis. Notably, MIF-2 lacks the pseudo-(E)LR motif present in MIF that mediates CXCR2 engagement and SPM migration, supporting a specific role for MIF in the recruitment and accumulation of inflammatory SPMs.

Entities:  

Keywords:  Cytokines; Immunology; Inflammation; Macrophages; Mouse models

Mesh:

Substances:

Year:  2021        PMID: 34850744      PMCID: PMC8631602          DOI: 10.1172/JCI127171

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  55 in total

1.  Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2.

Authors:  Julia L Gregory; Eric F Morand; Sonja J McKeown; Jennifer A Ralph; Pamela Hall; Yuan H Yang; Shaun R McColl; Michael J Hickey
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

2.  Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration.

Authors:  A Hermanowski-Vosatka; S S Mundt; J M Ayala; S Goyal; W A Hanlon; R M Czerwinski; S D Wright; C P Whitman
Journal:  Biochemistry       Date:  1999-09-28       Impact factor: 3.162

3.  Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome.

Authors:  S C Donnelly; C Haslett; P T Reid; I S Grant; W A Wallace; C N Metz; L J Bruce; R Bucala
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

4.  Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria.

Authors:  T Calandra; L A Spiegel; C N Metz; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

5.  Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.

Authors:  Tom Sprong; Peter Pickkers; Anneke Geurts-Moespot; Johanna van der Ven-Jongekrijg; Chris Neeleman; Marlies Knaup; Didier Leroy; Thierry Calandra; Jos W M van der Meer; Fred Sweep; Marcel van Deuren
Journal:  Shock       Date:  2007-05       Impact factor: 3.454

6.  A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice.

Authors:  Lin Leng; Liang Chen; Juan Fan; Dorothee Greven; Alvaro Arjona; Xin Du; David Austin; Michael Kashgarian; Zhinan Yin; Xiao R Huang; Hui Y Lan; Elias Lolis; David Nikolic-Paterson; Richard Bucala
Journal:  J Immunol       Date:  2010-11-24       Impact factor: 5.422

7.  MIF as a glucocorticoid-induced modulator of cytokine production.

Authors:  T Calandra; J Bernhagen; C N Metz; L A Spiegel; M Bacher; T Donnelly; A Cerami; R Bucala
Journal:  Nature       Date:  1995-09-07       Impact factor: 49.962

8.  Sepsis-induced potentiation of peritoneal macrophage migration is mitigated by programmed cell death receptor-1 gene deficiency.

Authors:  Alfred Ayala; Gwendolyn F Elphick; Ye Sul Kim; Xin Huang; Arnaldo Carreira-Rosario; Sadella C Santos; Nicholas J Shubin; Yaping Chen; Jonathan Reichner; Chun-Shiang Chung
Journal:  J Innate Immun       Date:  2013-11-16       Impact factor: 7.349

Review 9.  Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis.

Authors:  M Volbeda; J Wetterslev; C Gluud; J G Zijlstra; I C C van der Horst; F Keus
Journal:  Intensive Care Med       Date:  2015-06-23       Impact factor: 17.440

10.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

View more
  5 in total

Review 1.  Deep Insight into the Role of MIF in Spondyloarthritis.

Authors:  Brian Wu; Akihiro Nakamura
Journal:  Curr Rheumatol Rep       Date:  2022-07-09       Impact factor: 4.686

2.  Deciphering the Intercellular Communication Between Immune Cells and Altered Vascular Smooth Muscle Cell Phenotypes in Aortic Aneurysm From Single-Cell Transcriptome Data.

Authors:  Genmao Cao; Zhengchao Lu; Ruiyuan Gu; Xuezhen Xuan; Ruijing Zhang; Jie Hu; Honglin Dong
Journal:  Front Cardiovasc Med       Date:  2022-06-28

Review 3.  Macrophage Migration Inhibitory Factor (MIF) as a Stress Molecule in Renal Inflammation.

Authors:  Yao-Zhong Kong; Qiyan Chen; Hui-Yao Lan
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

Review 4.  Macrophage migration inhibitory factor in acute kidneyinjury.

Authors:  Yiwei Du; Hao Hao; Heng Ma; Hongbao Liu
Journal:  Front Physiol       Date:  2022-09-02       Impact factor: 4.755

5.  Ferroptosis in Macrophage Impairment in Sepsis.

Authors:  Hongxuan Liu; Lei Li
Journal:  Appl Bionics Biomech       Date:  2022-09-20       Impact factor: 1.664

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.